The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has provided a guidance on the human factors aspects of design for medical devices to ensure patient and user safety.

Intended for manufacturers, developers and notified bodies, the guidance focuses on the importance of human factors influence on safety risks.

The guidance includes design and optimisation of medical devices, as well as device components of drug-device combination products that are regulated as medicines.

A Human Factors Task and Finish group has been formed to support the initiative for patient safety and includes members from MHRA, academia, industry, NHS Improvement, NICE, notified bodies, professional associations, and trade bodies.

MHRA Devices director John Wilkinson said: “Medical devices are becoming ever more complex and diverse, encompassing drug-device combinations and companion diagnostics.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"It urges device manufacturers to apply a usability engineering process to identify, assess and reduce potential patient and user safety risks."

“As these developments occur, the potential for user error increases. We recognise this and have collaborated with partners to produce the first UK guidance on human factors.”

The guidance applies to the design of new devices and changes in user interfaces of existing products.

In addition to design, the guidance advises on testing and validation of design stages, as well as the post-market phase that might suggest certain design improvements during clinical practice.

It urges device manufacturers to apply a usability engineering process to identify, assess and reduce potential patient and user safety risks.

The process can also be applied during the analysis of prior incidents for identification and implementation of corrective actions to improve device design.